innovation compounding tirzepatide Compounded to Treat Diabetes led and built for women Compounded Tirzepatide for Women |

GLP-1 receptor agonists (GLP-1 RAs) were originally developed for type 2 diabetes but now have approved indications for weight-management

While GLP-1 is well-known for appetite suppression, GIP is thought to improve how the body breaks down sugar and fat

We do require more in order to thrive

This focus on physicianled care explains how clinical expertise supports safer, more personalized virtual treatment

You may experience tenderness and bruising where fat cells were removed, compression garments are helpful to reduce swelling

Mood and Blood Sugar Levels Tirzepatide delays how fast the stomach empties and changes how the body takes in glucose